Bain Capital Life Sciences Investors, LLC
At a glance: Bain Capital Life Sciences Investors, LLC is 10% Owner at Heartflow (HTFL). Their latest SEC Form 4, filed Feb 6, 2026, reported a sale of $56.1M. On file: 0 purchase lines ($0) and 1 sale line ($56.1M).
Disclosed holdings: about $471M of HTFL stock: 10,448,158 shares (including shares held indirectly, e.g. through a trust or fund) reported on its latest Form 4 (filed Feb 6, 2026), valued at the Nov 19, 2026 close of $45.05. This counts only HTFL shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
10% Owner at Heartflow, Inc. (HTFL)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Bain Capital Life Sciences Investors, LLC's InsiderPrint
4 trades from SEC Form 4 filings, 2021 to 2026, drawn as one fingerprint.
Reading this print: Mostly buys, trading about once a year, typically $2.0M a trade.
- Bump outward: a purchase (3)
- Dent inward: a sale (1)
- One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.
Insiders with a similar print
- John T. CahillDirector · ADSK · 97% matchTheir buys since 2020: 2 of 3 beat the S&P 500
- Eric J. FossCEO, Chair · PRMB · 97% match
- Randall J. WeisenburgerDirector · MP · 96% matchTheir buys since 2020: 2 of 4 beat the S&P 500
- Ares Management LLC10% Owner · CTEV · 96% match
- Samsara Biocapital, L.P.10% Owner · KLRS · 96% match
Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.
Reported trades
Follow Bain Capital Life Sciences Investors, LLC
Get one email when Bain Capital Life Sciences Investors, LLC files a new purchase or sale. Free.
At most one email a day about Bain Capital Life Sciences Investors, LLC, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.